Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas
Open Access
- 12 June 2014
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 37 (7) , 1910-1917
Abstract
OBJECTIVE: Previous studies evaluating the effect of metformin on cancer risk have been impacted by time-related biases. To avoid these biases, we examined the incidence of bladder cancer in new users of metformin and sulfonylureas (SUs). RESEARCH DESIGN AND METHODS: This cohort study included 87,600 patients with type 2 diabetes in The Health Improvement Network database. Use of metformin or an SU was treated as a time-dependent variable. Cox regression–generated hazard ratios (HRs) compared metformin use with SU use, adjusted for age, sex, smoking, obesity, and HbA1c level. RESULTS: We identified 196 incident bladder cancers in the metformin cohort and 66 cancers in the SU cohort. Use of metformin was not associated with decreased bladder cancer risk (HR 0.81 [95% CI 0.60–1.09]). This association did not differ by sex (P for interaction = 0.20). We observed no association with duration of metformin relative to SU use (3 to <4 years of use: 0.57 [0.25–1.34]; 4 to <5 years of use: 0.93 [0.30–2.85; ≥5 years of use: 1.18 [0.44–3.19]; P for trend = 0.26). CONCLUSIONS: Use of metformin is not associated with a decreased incidence of bladder cancer. Similar methods should be used to study other cancers that have previously been identified as potentially preventable with metformin.Keywords
This publication has 39 references indexed in Scilit:
- Phase II study of everolimus in metastatic urothelial cancerBJU International, 2013
- Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer CellsClinical Cancer Research, 2011
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individualsBMC Cancer, 2011
- Metformin and Incident Breast Cancer among Diabetic Women: A Population-Based Case–Control Study in DenmarkCancer Epidemiology, Biomarkers & Prevention, 2011
- The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancersBJU International, 2010
- Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinomaCancer, 2010
- Long-Term Metformin Use Is Associated With Decreased Risk of Breast CancerDiabetes Care, 2010
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetesDiabetologia, 2009
- New Users of Metformin Are at Low Risk of Incident CancerDiabetes Care, 2009
- The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein KinaseCancer Prevention Research, 2008